YOKOHAMA, Japan--(BUSINESS WIRE)--ReproCELL, Inc. (JASDAQ: 4978) announces that at a director meeting held on November 24th, 2015, the complete subsidiary acquisition of English company Biopta Limited (hereafter referred to as Biopta) was decided upon.
Our company group has up to now been involved in the global development of research reagent products and cell products through its use of cutting edge techniques involving human iPS cells, and continues healthy business expansion in said market, which is showing remarkable development.
